Stanford researchers have developed a novel mutant IL-9 receptor (IL9R) that significantly enhances the in vivo engraftment, expansion, and anti-tumor activity of adoptively transferred T cells.
Stanford researchers have developed MONTAGE, a powerful computational framework designed to identify groups of cells, called spatial communities, and map how these groups change across biological functions linked to cancer progression.
Stanford researchers have developed an innovative method for efficiently generating robust lymphatic endothelial cells (iLECs) from human induced pluripotent stem cells (hiPSCs) through transcription factor-based protocols.
Stanford researchers have identified a small set of genes that can be used to diagnose active tuberculosis (TB), distinguish active TB from latent TB or other diseases, and predict progression from latent to active TB months before conventional tests.
Stanford scientists have designed a passive and active polarization-insensitive grating coupler that enables consistent fiber-to-chip light coupling regardless of input polarization state.
Stanford researchers have developed a system that assesses altered mental states in both human and animal subjects using neural biomarkers, allowing for repeatable cross-species studies of potential treatments for psychiatric and neurological disorders.
Stanford researchers Robert Lowsky and Samuel Strober have developed a strategy for maintaining normal graft function without immune suppression medication. Kidney transplant recipients require lifelong use of immunosuppressants to minimize rejection risk.
Researchers at Stanford have developed methods and compositions to provide inducible production of anti-inflammatory cytokines in mesenchymal stem cells (MSCs).
Researchers at Stanford developed a novel technique to induce persistent mixed hematopoietic cell chimerism in organ recipients to protect against organ graft rejection and increase immune tolerance.
Stanford scientists have developed a plant-derived zinc protoporphyrin (ZnPP) produced from legume hemoglobin, a breakthrough therapy candidate for treating neonatal jaundice.
Stanford researchers have developed a novel blood-based diagnostic platform that leverages circulating bacteriophage DNA (phage cfDNA) to enable sensitive and highly specific detection of both overt and subclinical bacterial infections, while effectively discriminating them fr